SCHEMBL2148441

SCHEMBL2148441

C=C(C)COC(=O)CCCC(=O)O

nearest known ligand 0.52

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
TSHR P16473 7/20 0.52
PAM P19021 2/20 0.48
SLC22A6 Q4U2R8 2/20 0.44
LMNA P02545 2/20 0.39
NFKB1 P19838 1/20 0.37
PMP22 Q01453 1/20 0.37
AKR1B1 P15121 1/20 0.37
ALDH1A1 P00352 3/20 0.36
NPC1 O15118 1/20 0.36
PPARG P37231 6/20 0.35
PPARD Q03181 6/20 0.35
PPARA Q07869 6/20 0.35
HDAC11 Q96DB2 5/20 0.35
GPR84 Q9NQS5 4/20 0.35
TLR2 O60603 2/20 0.35
TDP1 Q9NUW8 2/20 0.35
FABP4 P15090 2/20 0.35
PTPN1 P18031 2/20 0.35
SLC22A8 Q8TCC7 1/20 0.35
MEN1 O00255 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5285283 0.88 EGLN1 (0.43) TSHRPAMSLC22A6LMNAALDH1A1
SCHEMBL17169822 0.87 PAM (0.50) TSHRPAMLMNAALDH1A1TDP1
SCHEMBL1515413 0.83 TSHR (0.56) TSHRPAMSLC22A6LMNANFKB1
SCHEMBL23049031 0.82 TSHR (0.50) TSHRPAMSLC22A6LMNANFKB1
SCHEMBL9133055 0.82 PAM (0.41) TSHRPAMLMNAALDH1A1TDP1
SCHEMBL3504158 0.82 PAM (0.55) TSHRPAMLMNAALDH1A1TDP1
SCHEMBL585970 0.81 PAM (0.63) TSHRPAMSLC22A6LMNANFKB1
SCHEMBL3503610 0.80 PAM (0.63) TSHRPAMLMNAALDH1A1MEN1
SCHEMBL3503950 0.78 PAM (0.67) TSHRPAMLMNAALDH1A1MEN1
SCHEMBL3504155 0.78 PAM (0.67) TSHRPAMLMNAALDH1A1MEN1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 9 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8591923-B2 Cosmetic compositon comprising a (thio)urethane/(thio)urea copolymer capable of forming at least 3 hydrogen bonds, and a method of cosmetic treatment L'OREAL (FR) 2013-11-26 US claimed
US-20070189991-A1 Cosmetic compositon comprising a (Thio)urethane/ (thio)urea copolymer capable of forming at least 3 hydrogen bonds, and a method of cosmetic treatment L'OREAL S.A. (FR) 2007-08-16 US claimed
EP-1797868-A1 Cosmetic composition comprising a (thio)urethane/(thio)urea copolymer capable of forming at least 3 hydrogen bonds, and process for cosmetic treatment L'Oréal (FR) 2007-06-20 EP claimed
EP-2729118-A2 COSMETIC TREATMENT PROCESSES AND KIT L'OREAL (FR) 2014-05-14 EP disclosed
US-8591923-B2 Cosmetic compositon comprising a (thio)urethane/(thio)urea copolymer capable of forming at least 3 hydrogen bonds, and a method of cosmetic treatment L'OREAL (FR) 2013-11-26 US disclosed
WO-2013004982-A2 COSMETIC TREATMENT PROCESSES AND KIT L'OREAL (FR) 2013-01-10 WO disclosed
WO-2011083243-A1 COSMETIC TREATMENT METHODS AND KIT L'OREAL (FR) 2011-07-14 WO disclosed
US-20070189991-A1 Cosmetic compositon comprising a (Thio)urethane/ (thio)urea copolymer capable of forming at least 3 hydrogen bonds, and a method of cosmetic treatment L'OREAL S.A. (FR) 2007-08-16 US disclosed
EP-1797868-A1 Cosmetic composition comprising a (thio)urethane/(thio)urea copolymer capable of forming at least 3 hydrogen bonds, and process for cosmetic treatment L'Oréal (FR) 2007-06-20 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20070189991-A1 Cosmetic compositon comprising a (Thio)urethane/ (thio)urea copolymer capable of forming at least 3 hydrogen bonds, and a method of cosmetic treatment KRT18, TST, CTH TSHR 2129/4885PAM 791/4885SLC22A6 4723/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.